EQS-News: Carl Zeiss Meditec AG / Key word (s): Quarterly / Interim Statement/Quarter Results Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25 12.02.2025 / 06:58 ...
The experimental protocol was approved by The Administration of the Republic of Slovenia for Food Safety, Veterinary and Plant Protection (Republic of Slovenia, Ministry of Agriculture, Forestry and ...
The Xradia Versa family is the latest generation of 3D X-ray microscopy (XRM) solutions optimized for non-destructive micro tomography. Xradia 510 Versa advances industry and science with a ...
This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...
Combine scanning electron microscopy and elemental analytics: the best-in-class EDS geometry of Sigma increases your analytical productivity, especially on beam sensitive samples. Get analytical ...
Zeiss binoculars are top quality, with a price tag to match, but you can save some serious money with these Zeiss bino deals. When you purchase through links on our site, we may earn an affiliate ...
This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...
In a historic first, Marcel Barrera’s heroic bus driver heart warmer “The 47” and Arantxa Echevarría’s terrorist org infiltrator thriller “Undercover” became the first films ever to ...
On Wednesday, Goldman Sachs analyst Richard Felton upgraded Carl Zeiss Meditec AG (AFX:GR) (OTC: CZMWY), a medical technology company with a $5.2 billion market cap, from Sell to Neutral and ...
Among the highlighted products is the ZEISS EXTARO® 300 surgical microscope, designed for microscope-assisted dental procedures with advanced features like caries detection and optimal lighting. ZEISS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results